DermTech, Inc. (DMTK) Financials

DMTK Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 121.9 million 64.8 million
2023-09-30 137.9 million 64.8 million
2023-06-30 157.1 million 69.0 million
2023-03-31 177.1 million 69.9 million

DMTK Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -12.5 million 3.2 million
2023-09-30 -19.1 million 3.2 million
2023-06-30 -23.5 million 7.5 million
2023-03-31 -22.8 million 4.7 million

DMTK Net Income

No data available :(

DMTK Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 55.9 million - 54.4 million
2023-09-30 68.2 million - 55.2 million
2023-06-30 86.2 million - 55.3 million
2023-03-31 104.8 million - 55.6 million

DMTK Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 34.3 million
2023-09-30 33.8 million
2023-06-30 31.8 million
2023-03-31 30.6 million

DMTK Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 163000 3.3 million 8.4 million 8.4 million
2023-09-30 49000 3.6 million 8.3 million 8.1 million
2023-06-30 259000 3.9 million 15.2 million 13.0 million
2023-03-31 757000 4.4 million 11.9 million 15.4 million

DMTK Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.9 million 3.5 million
2023-09-30 3.9 million 3.7 million
2023-06-30 4.0 million 4.0 million
2023-03-31 3.5 million 3.8 million

DMTK

Price: $0.63

52 week price:
0.57
4.67

Earnings Per Share: -3.09 USD

P/E Ratio: -0.37

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 368700

Market Capitalization: 22.0 million

Links: